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Abstract Alterations in the Superoxide dismutase (SOD) 
content of thyroid tissues occurring in association with thyroid 
dysfunction have been reported. In this study, the Mn-SOD 
content was found to increase in thyroid tissues of rats 
administered thyroid stimulating hormone (TSH) and in 
thyrocytes cultured in medium supplemented with TSH. 
Furthermore, in the thyroid glands of rats whose serum TSH 
level was elevated by inhibiting the synthesis of T3 and T4 by 6-
methyl-2-thiouracil, the Mn-SOD increased as the TSH 
concentration increased. In the cultured thyrocytes, the increase 
in Mn-SOD induced by TSH was inhibited by the C-kinase 
inhibitor H7. These findings suggest the induction of Mn-SOD 
by TSH in thyroid cells and point to a role of C-kinase in this 
process, thereby indicating that a close relationship exists 
between the serum TSH level and the change in Mn-SOD 
content in thyrocytes with thyroid dysfunction. 
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1. Introduction 
Superoxide dismutase (SOD), which catalyzes the dismuta-
tion of Superoxide anion (0^~), is present as three types of 
isoenzyme in mammalian tissues, designated CuZn-SOD, 
Mn-SOD and extracellular SOD [1,2]. The roles of SOD in 
the thyroid gland have been reported to include not only the 
protection of cells from radicals, but also involvement in the 
production of H2O2 as a substrate of thyroid peroxidase, a 
necessary process for the synthesis of thyroid hormone [3]. 
However, Nakamura et al. reported that the plasma mem-
brane in thyroid cells contained a NADPH-dependent 
H2O2 -generating system which provided Н2Ог for the thyroid 
peroxidase-catalyzed biosynthesis of thyroid hormones and 
that it had no Superoxide dismutase activity [4,5]. Thus, no 
clear description of the role of SOD in thyroid gland cells has 
yet been offered. 
Moreover, a large number of observations have been made 
on SOD activities associated with various diseases. In partic-
ular, changes in Mn-SOD content in association with thyroid 
Corresponding author. Fax: (81) (723) 60-2028. 
E-mail: nishida@med.kindai.ac.jp 
Abbreviations: SOD, Superoxide dismutase; Mn-SOD, manganese 
containing Superoxide dismutase; TSH, thyroid stimulating hormone; 
TNFos, tumor necrosis factor-α; MTU, 6-methyl-2-thiouracil; ELISA, 
enzyme-linked immunosorbent assay; IL-1, interleukin-1 
dysfunction have been reported [6,7]. According to Asayama 
et al. [6], T4-treated rats had an increased Mn-SOD activity 
and content in smooth muscle and heart. According to Ohno 
et al. [7], serum Mn-SOD levels were found to be respectively 
low and high for hyperthyroidism and hypothyroidism, and 
treatment of hypothyroidism with thyroid hormone resulted 
in a return of the Mn-SOD content to the normal level. No 
conclusions have been reached regarding the mechanism by 
which changes in Mn-SOD content are related to thyroid 
dysfunction. 
We previously reported the immunohistochemical demon-
stration of a high level of expression of Mn-SOD in thyroid 
follicular cells of a patient with Hashimoto thyroiditis with a 
high serum thyroid stimulating hormone (TSH) level [8], and 
suggested the possibility that Mn-SOD is induced by TSH. 
The aim of the present study was to determine whether or 
not Mn-SOD was induced by TSH in thyroid cells. 
2. Materials and methods 
2.1. Culture of thyrocytes 
Male Wistar rats (8 weeks of age) were used for the experiments. 
The rats were killed after having been anesthetized with ether. The 
dissected thyroid glands were finely minced and treated with 0.1% 
collagenase (type I, Sigma)+0.2% dispase (Godo Shusei) for 30-120 
min at 37°C. The cells were collected by centrifugation at 90 Xg for 
3 min and washed several times with Hanks' balanced salt solution. 
This was followed by centrifugation at 90Xg for 1 min. Cells were 
cultured in plastic dishes in Dulbecco's modified Eagle medium (Nis-
sui Seiyaku) supplemented with 10% fetal bovine serum (Gibco) or 
10% fetal bovine serum+TSH (100 μυ/ml, Sigma), TNFot (100 ng/ml, 
Genzyme) and forskolin (100 μΜ, Funakoshi) in a humidified incu-
bator in an atmosphere containing 5% СО2. Thyroid follicle cells were 
preincubated with the C-kinase inhibitor H7 (50 μΜ, Seikagaku), and 
after 4 h, TSH (100 μυ/ml) was added to the medium. Twenty-four 
hours after drug treatments, these cells were collected for measure-
ment of Mn-SOD content. 
2.2. Exogenous TSH stimulation by subcutaneous injection of TSH 
Male Wistar rats were administered TSH by subcutaneous injection 
at three different doses (0.5, 5, 50 mU/animal). The rats were killed at 
two different time intervals after TSH injection: 24 and 48 h. The 
thyroid glands were dissected and freed of adhering connective tissues, 
and blood was removed by washing several times with chilled phys-
iological saline. The remaining tissue was then used for measurement 
of Mn-SOD content. 
2.3. Endogenous TSH stimulation by administration of 
6-methyl-2-thiouracil (MTU) 
Male Wistar rats were given drinking water containing 1% MTU 
(inhibitor of thyroid hormone synthesis, Nakarai). The rats were 
killed after 0, 1, 2, 5, and 10 days of MTU treatment. Dissected 
thyroid tissue was used for the measurement of Mn-SOD content 
and activity. Serum was used for the measurement of T4, T3 and 
TSH. 
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Fig. 1. Induction of Mn-SOD by TSH and TNFoc in cultured thyro-
cytes. The increase in Mn-SOD content was observed after the addi-
tion of TNFa (100 μυ/ml) or TSH (100 ng/ml). Data are the 
mean ± S.E.M. (и = 5). 
2.4. Preparation of materials 
The cultured cells or the tissues were immediately frozen in liquid 
N2 and stored at —80°C until the Mn-SOD content was measured. 
The frozen samples were placed in 20 mM Tris-HCl buffer (pH 7.4) 
and homogenized in a Polytron homogenizer, then the homogenate 
was centrifuged at 500 Xg for 10 min. The supernatants were used for 
the ELISA. The protein content of the homogenate was determined 
using а ВС A protein assay kit (Pierce). 
2.5. Serum T4, T3 and TSH 
The serum concentrations of T4, T3 and TSH were measured by 
radioimmunoassay: T4 with the Amerlex-MAB-T4 radioimmunoas-
say kit (Amersham), T3 with the Amerlex-MAB-T3 radioimmunoas-
say kit (Amersham), and TSH by radioimmunoassay with the rat 
TSH-125I assay system (Amersham). 
2.6. Mn-SOD content 
ELISA was performed essentially as described by Kawaguchi et al. 
[9,10]. Measurement of Mn-SOD was carried out using polyclonal 
antibody raised against rat liver Mn-SOD [9]. 
2.7. Mn-SOD activity 
The assay of SOD activity was basically as described by Beachap 
and Fridovich [11]. Briefly, the assay was based on the inhibition of 
nitroblue tetrazolium conversion by SOD into a blue tetrazolium salt, 
mediated by Superoxide radicals which had been generated by xan-
thine oxidase. The amount required to inhibit the rate of reduction of 
nitroblue tetrazolium by 50% was defined as 1 unit of activity. For 
inhibition of the CuZn-SOD activity, the assay was conducted in the 
presence of 2 mM NaCN after preincubation for 30 min. 
3. Results and discussion 
In our experiments, cultured thyroid cells were positive to 
anti-thyroglobulin antibody when tested immunohistologi-
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Fig. 2. Induction of Mn-SOD content in TSH-treated rat thyroid 
tissues. Administration of exogenous TSH (0.5, 5 and 50 mU/ani-
mal) produced dose- and time-dependent increases in Mn-SOD in 
the thyroid gland. Data are the mean ± S.E.M. (n = 4). 
cally, and manifested distinct cytoplasmic dilatation 24 h after 
the addition of TSH. In thyroid follicle cells, the induction of 
Mn-SOD by TNFa has been reported. Similarly, in our ex-
periments, the addition of TNFa resulted in a significant in-
crease in Mn-SOD content, to approximately four times that 
in the control. Similarly, the addition of TSH resulted in an 
increase in Mn-SOD content, to approximately twice that in 
the control; this rate of induction was less than that for 
TNFa (Fig. 1). 
In TSH-treated rats (exogenous TSH stimulation), increases 
in Mn-SOD content in thyroid tissues depending upon the 
dose of TSH were noted at 24 and 48 h after TSH adminis-
tration (Fig. 2). The increase in the ratio of Mn-SOD content 
was higher at 48 h than at 24 h after TSH administration (Fig. 
2). 
In order to promote endogenous stimulation of TSH secre-
tion, MTU in doses known to inhibit thyroid hormone syn-
thesis was administered to rats. The serum TSH level was 
elevated by MTU treatment, and Mn-SOD activity and con-
tent in thyrocytes increased as well depending on the increase 
in the serum TSH level (Fig. 3). 
In the present study, TSH administration was found to 
increase Mn-SOD content in the thyroid gland both in vivo 
and in vitro. These findings indicate that TSH induces Mn-
SOD in thyroid cells, and agreed well with the findings of our 
previous study that thyroid follicular cells in a patient with 
Hashimoto thyroiditis had high serum TSH levels and showed 
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Fig. 3. Relationship between Mn-SOD induction and changes in serum TSH, T3, and T4 levels in MTU-treated rats. Serum levels of endoge-
nous TSH were elevated by MTU treatment, and the content and activity of Mn-SOD increased in association with this elevation. However, 
the serum T3 and T4 levels showed significant inverse decreases. Data are the mean ± S.E.M. (n - 4-6). 
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Fig. 4. Inhibitory effect of H7 in Mn-SOD induction by TSH in cul-
tured thyrocytes. Pretreatment of the C-kinase inhibitor H7 (50 μΜ) 
inhibited the increase in Mn-SOD by TSH. Furthermore, the addi-
tion of the adenylate cyclase activator forskolin (100 μΜ) did not 
cause any increase in Mn-SOD content. Data are the mean ± S.E.M. 
(n = 4-7). 
strongly positive immunohistological staining for anti-Mn-
SOD antibody [8]. 
It has been reported that Mn-SOD was increased in the 
muscle of rats administered T4 [6,12]. The results of the 
present experiment also indicate the possibility that Mn-
SOD was induced by T4, which was secreted from the thyroid 
follicle cells in response to the addition of TSH. Accordingly, 
we administered the thyroid hormone synthesis inhibitor, 
MTU, and examined changes occurring in Mn-SOD levels 
when the endogenous T4 level was lowered. In MTU-treated 
rats, the serum TSH level increased significantly, and the con-
tent and activity of Mn-SOD of the thyroid tissue also in-
creased in association with the increase. However, in contrast, 
the T3 and T4 levels showed marked decreases after treatment 
(Fig. 3). These results suggest that the induction of Mn-SOD 
in thyroid cells is not affected by T3 and T4, but, in contrast, 
is affected by TSH. 
As described above, the induction of Mn-SOD by TNFa, 
IL-1 and LPS has already been reported [13,14]. Although the 
mechanism by which Mn-SOD induction occurs is largely 
unknown, it has been suggested that protein kinase С is in-
volved [15], since 12-O-tetradecanoylphorbol 13-acetate stim-
ulation can result in the induction of Mn-SOD. The increase 
in Mn-SOD by TSH was inhibited in part by the C-kinase 
inhibitor H7, and no increase was seen in the Mn-SOD con-
tent of the cells cultured in the presence of forskolin (Fig. 4). 
TSH is a known activator of the processes of both adenylate 
cyclase and C-kinase [16,17]. This suggests a close relationship 
between C-kinase and some part of the mechanism of Mn-
SOD induction by TSH confirmed in the present experiment. 
Moreover, IL-1, which can induce Mn-SOD, is known to 
inhibit thyroid function in a concentration-dependent manner 
in human thyrocytes [18]. Thus IL-1 appears to have impor-
tant roles in modulating change in both the Mn-SOD content 
and thyroid function in patients with thyroid dysfunction. 
However, the previous finding (Fig. 1) that Mn-SOD was 
induced by TSH in thyrocytes cultured in medium without 
change in the IL-1 and TNFa contents may partly explain 
the alteration in Mn-SOD content that occurs in association 
with thyroid dysfunction. However, the biological roles of 
SOD and the physiological relationship existing between 
TSH and Mn-SOD are not yet clearly understood, and will 
require further study. 
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